作者：
Maxson,J.E. [1]
;
Gotlib,J. [2]
;
Pollyea,D.A. [3]
;
Fleischman,A.G. [4]
;
Agarwal,A. [5]
;
Eide,C.A. [6]
;
Bottomly,D. [7]
;
Wilmot,B. [8]
;
McWeeney,S.K. ;
Tognon,C.E. ;
Pond,J.B. ;
Collins,R.H. ;
Goueli,B. ;
OhMichaelWDeininger,S.T. ;
Chang,B.H. ;
Loriaux,M.M. ;
Druker,B.J. ;
Tyner,J.W.
作者单位：
Hematology/Oncology, Department of Internal Medicine, University of Texas Southwestern Medical
[1]
Knight Cancer Institute, Oregon Health and Science University, Portland, OR, United States
[2]
Department of Medicine, Washington University School of Medicine, Washington University in St
[3]
Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, United States
[4]
Division of Hematology, Oncology, and Bone Marrow Transplantation, University of Colorado School of
[5]
Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, OR
[6]
Knight Cancer Institute, Oregon Health and Science University, Portland, OR, United States, Oregon
[7]
St. Luke's Oncology and Hematology, St. Luke's Regional Cancer Center, Duluth, MN, United States
[8]
发布时间
2013-11-20
换一批
